Articles > Popular publications > PR Newswire press releases > October-December 2000 > Monday, October 2

Article: Dura Pharmaceuticals Acquires Exclusive Distribution Rights From Glaxo Wellcome for Dermatology Product Line.

Article from:
PR Newswire
Article date:
October 2, 2000
Copyright

Dura to Enter Another Specialty-Focused Market by Creating

A Dermatology Division

SAN DIEGO, Oct. 2 /PRNewswire/ --

Dura Pharmaceuticals, Inc. (Dura) (Nasdaq: DURA) today announced that it has signed with Glaxo Wellcome, Inc., a wholly-owned subsidiary of Glaxo Wellcome, plc (Glaxo) (NYSE: GLX), an exclusive U.S. distribution agreement with a purchase option for Glaxo's dermatological product line, consisting of Cutivate(R) (fluticasone propionate), Temovate(R) (clobetasol propionate), Aclovate(R) (alclometasone dipropionate), Oxistat(R) (oxiconazole nitrate) and Emgel(R) (erythromycin) in all current sizes, strengths and formulations. The ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: DURA Pharmaceuticals Inc.(Signed agreement w/ Glaxo ...
Chemical Market Reporter;  October 9, 2000 ;     572 words ...DURA Pharmaceuticals Inc. has signed an exclusive ... agreement with a purchase option for Glaxo Wellcome's dermatological product line. The ... manufacture and supply of the products for Dura, and Dura will make annual payments in 2001 and ...

Article: Glaxo Wellcome, NeXstar Pharmaceuticals Sign ...
PR Newswire;  May 27, 1998 ;     700+ words ... ... Pharmaceuticals, Inc. (Nasdaq: NXTR) and Glaxo Wellcome (London: GLXO) announced today a ... collaboration, including a license by Glaxo Wellcome for the use of NeXstar Pharmaceuticals ... research tool for target validation in Glaxo Wellcome's functional genomics programs ...

Article: Glaxo Wellcome Signs $1.3M Deal with Domain ...
Business Wire;  January 19, 1999 ;     700+ words ... ... HealthWire)--Jan. 19, 1999-- Glaxo Wellcome hopes to gain unique competitive advantage ... company has signed an agreement with Glaxo Wellcome, Inc., a leading research-based ... Starfire(TM) Groupware system to Glaxo Wellcome development and manufacturing sites ...

Article: PowderJect & Glaxo Wellcome Sign DNA Vaccine ...
PR Newswire;  March 4, 1998 ;     700+ words ... ... plc (London: PJP) (PowderJect) and Glaxo Wellcome plc (London: GLXO) (Glaxo Wellcome) today announced that the two companies ... license and option agreement granting Glaxo Wellcome exclusive, worldwide rights to develop ...

Article: CuraGen and Glaxo Wellcome Initiate ...
PR Newswire;  November 20, 1998 ;     700+ words ... ... Technologies to Accelerate Evaluation of Glaxo Wellcome Preclinical Drug Pipeline NEW HAVEN ... CuraGen Corporation (Nasdaq: CRGN) and Glaxo Wellcome Inc. (NYSE: GLX) announced today ... processes for the study and selection of Glaxo Wellcome compounds for clinical development ...

Article: VERTEX AND GLAXO WELLCOME OBTAIN LICENSE TO G.D. ...
PR Newswire;  July 1, 1996 ;     700+ words ... ... Incorporated (Nasdaq: VRTX) and Glaxo Wellcome plc (NYSE: GLX) announced today ... The companies also announced that Glaxo Wellcome has made a $5 million equity investment ... Vertex. With the license, Vertex and Glaxo Wellcome can continue to develop, manufacture ...

Article: Catalytica To Buy Glaxo Wellcome Pharmaceutical ...
PR Newswire;  February 5, 1997 ;     700+ words ...Company To Produce Medicines For Glaxo Wellcome; Minimal Impact Seen In Employment ... C., Feb. 5 /PRNewswire/ -- Glaxo Wellcome Inc. and Catalytica Inc. (Nasdaq ... of intent for Catalytica to acquire Glaxo Wellcome's pharmaceutical production facility ...

Article: Proposed Merger of Glaxo Wellcome and SmithKline ...
PR Newswire;  January 17, 2000 ;     700+ words ... ... conditions or undertakings of Glaxo Wellcome or SmithKline Beecham that are not satisfactory to both Glaxo Wellcome and SmithKline Beecham and, in ... receipt in a form satisfactory to Glaxo Wellcome and SmithKline Beecham of confirmation ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives